Prediction of cancer outcome with microarrays: A multiple random validation strategy

Lancet

Volumn 365, Issue 9458, 2005, Pages 488-492

  Michiels, Stefan ^a   Koscielny, Serge ^a   Hill, Catherine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; RANDOMIZATION; STANDARD; TECHNIQUE; TRAINING; VALIDATION PROCESS;

EID: 13444249852     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)17866-0     Document Type: Article

References (17)

1. Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet. 362:2003;1439-1444
2. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 346:2002;1937-1947
3. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:2002;133-143
4. vant't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536
5. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8:2002;816-824
6. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 98:2001;13790-13795
7. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:2003;49-54
8. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415:2002;436-442
9. Iizuka N, Oka M, Yamada-Okabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 361:2003;923-929
10. Caldas C, Aparicio SA. The molecular outlook. Nature. 415:2002;484-485
11. Kallioniemi O. Medicine: profile of a tumour. Nature. 428:2004;379-382
12. Miller LD, Long PM, Wong L, Mukherjee S, McShane LM, Liu ET. Optimal gene expression analysis by microarrays. Cancer Cell. 2:2002;353-361
13. Simon R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer. 89:2003;1599-1604
14. Microarray Gene Expression Data (MGED). A guide to microarray experiments - an open letter to the scientific journals. Lancet. 360:2002;1019
15. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME): toward standards for microarray data. Nat Genet. 29:2001;365-371
16. van de Vijver MJ, He YD, vant't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:2002;1999-2009
17. Dudoit S, Fridlyand J, Speed TP. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc. 97:2002;77-87